IKK/IκB inhibitor PHA 408, Purity ≥98%

Cat. No.: X23-10-ZQ769

IKK/IκB inhibitor PHA 408, Purity ≥98%

Synonym: PHA-408; 503555-55-3; PHA 408; PHA408; 8-(5-Chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-1-(4-fluorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide; IKK/IκB inhibitor

  • CAS Number: 503555-55-3
  • Compound CID: 22291652
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PHA 408 modulates IKK-IκB signaling pathway, which plays a key role in inflammation and immune responses.
Molecular Weight
560.02
Molecular Formula
C29H27ClFN7O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
PHA 408 can be used to investigate its role as an inhibitor of IKK-2 in the NF-κB signaling pathway in inflammatory disease models.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0